nach oben

Clinical Research in Cardiology

Erschienen in:

01.06.2015 | Letter to the Editors

Very late cardiac tamponade following successful transcatheter closure of an atrial septal defect with the Amplatzer septal occluder

verfasst von: Thomas Herren, Michael Schwanda, Michele Genoni, Franz R. Eberli

Erschienen in: Clinical Research in Cardiology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Excerpt

Sirs: …

Nur mit Berechtigung zugänglich

Butera G, Biondi-Zoccai G, Sangiorgi G, Abella R, Giamberti A, Bussadori C, Sheiban I, Saliba Z, Santoro T, Pelissero G, Carminati M, Frigiola A (2011) Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence. EuroIntervention 7(3):377–385. doi:10.4244/EIJV7I3A63 CrossRefPubMed

DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE Jr (2009) Analysis of the US Food and Drug Administration Manufacturer and user facility device experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg 137(6):1334–1341. doi:10.1016/j.jtcvs.2009.02.032 CrossRefPubMedCentralPubMed

Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J (2005) Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 45(8):1213–1218. doi:10.1016/j.jacc.2004.12.072 CrossRefPubMed

Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E (2010) ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 31(23):2915–2957. doi:10.1093/eurheartj/ehq249 CrossRefPubMed

Kotowycz MA, Therrien J, Ionescu-Ittu R, Owens CG, Pilote L, Martucci G, Tchervenkov C, Marelli AJ (2013) Long-term outcomes after surgical versus transcatheter closure of atrial septal defects in adults. JACC Cardiovasc Interv 6(5):497–503. doi:10.1016/j.jcin.2012.12.126 CrossRefPubMed

Abaci A, Unlu S, Alsancak Y, Kaya U, Sezenoz B (2013) Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies. Catheter Cardiovas Interv 82:1123–1138. doi:10.1002/ccd.24875 CrossRef

Roberts WT, Parmar J, Rajathurai T (2013) Very late erosion of Amplatzer septal occluder device presenting as pericardial pain and effusion 8 years after placement. Catheter Cardiovasc Interv 82(4):E592–E594. doi:10.1002/ccd.24755 PubMed

Sarris GE, Kirvassilis G, Zavaropoulos P, Belli E, Berggren H, Carrel T, Comas JV, Corno AF, Daenen W, Di Carlo D, Ebels T, Fragata J, Hamilton L, Hraska V, Jacobs J, Lazarov S, Mavroudis C, Metras D, Rubay J, Schreiber C, Stellin G (2010) Surgery for complications of trans-catheter closure of atrial septal defects: a multi-institutional study from the European Congenital Heart Surgeons Association. Eur J Cardiothorac Surg 37(6):1285–1290. doi:10.1016/j.ejcts.2009.12.021 CrossRefPubMed

Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS (2004) Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 63(4):496–502. doi:10.1002/ccd.20211 CrossRefPubMed

10.

Amplatzer septal occluder delivery system - instructions for Use, St. Jude Medical (2014) http://manuals.sjm.com/Search-Form?re=North-America&cc=US&ln=all&fam=db52be0a-e057-428d-9897-67e1e67f542e&cat=71260c89-7cb8-475d-950b-0262191e7526&seg=dd28d64f-7d0b-4660-aa2c-da987bb7894c&ipp=10. Accessed January 25, 2015

11.

Moore J, Hegde S, El-Said H, Beekman R 3rd, Benson L, Bergersen L, Holzer R, Jenkins K, Ringel R, Rome J, Vincent R, Martin G, Committee AIS (2013) Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv 6(5):433–442. doi:10.1016/j.jcin.2013.02.005 CrossRefPubMed

12.

El-Said HG, Moore JW (2009) Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations? Catheter Cardiovasc Interv 73(7):925–930. doi:10.1002/ccd.21931 CrossRefPubMed

13.

Schubert S, Kainz S, Peters B, Berger F, Ewert P (2012) Interventional closure of atrial septal defects without fluoroscopy in adult and pediatric patients. Clinical Res Cardiol 101(9):691–700. doi:10.1007/s00392-012-0445-1 CrossRef

14.

Javois AJ, Rome JJ, Jones TK, Zahn EM, Fleishman CE, Pignatelli RH, Latson LA, Gore HCASG (2014) Results of the U.S. Food and Drug Administration continued access clinical trial of the GORE HELEX septal occluder for secundum atrial septal defect. JACC Cardiovasc Interv 7(8):905–912. doi:10.1016/j.jcin.2014.01.169 CrossRefPubMed

15.

Mullen MJ, Hildick-Smith D, De Giovanni JV, Duke C, Hillis WS, Morrison WL, Jux C (2006) BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation 114(18):1962–1967. doi:10.1161/CIRCULATIONAHA.106.664672 CrossRefPubMed

Titel: Very late cardiac tamponade following successful transcatheter closure of an atrial septal defect with the Amplatzer septal occluder
verfasst von: Thomas Herren
Michael Schwanda
Michele Genoni
Franz R. Eberli
Publikationsdatum: 01.06.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Research in Cardiology / Ausgabe 6/2015
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-015-0829-0

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Very late cardiac tamponade following successful transcatheter closure of an atrial septal defect with the Amplatzer septal occluder

Excerpt

Neu im Fachgebiet Kardiologie

Ist Fasten vor Koronarinterventionen wirklich nötig?

PET kann infarktgefährdete Koronararterien entdecken

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2015

Reducing radiation exposure during invasive coronary angiography and percutaneous coronary interventions implementing a simple four-step protocol

CT-proET1 predicts pulmonary hemodynamics in Scleroderma-associated pulmonary hypertension

Diagnostic accuracy of computed tomography angiography for the detection of coronary artery disease in patients referred for transcatheter aortic valve implantation

Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study

Radial artery applanation tonometry for continuous noninvasive arterial blood pressure monitoring in the cardiac intensive care unit

Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry

Neu im Fachgebiet Kardiologie

Ist Fasten vor Koronarinterventionen wirklich nötig?

PET kann infarktgefährdete Koronararterien entdecken

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Kardiologie